BRPI0800601A2 - dose-booster vaccination method for malaria using recombinant viruses and vaccine composition - Google Patents
dose-booster vaccination method for malaria using recombinant viruses and vaccine compositionInfo
- Publication number
- BRPI0800601A2 BRPI0800601A2 BRPI0800601-6A BRPI0800601A BRPI0800601A2 BR PI0800601 A2 BRPI0800601 A2 BR PI0800601A2 BR PI0800601 A BRPI0800601 A BR PI0800601A BR PI0800601 A2 BRPI0800601 A2 BR PI0800601A2
- Authority
- BR
- Brazil
- Prior art keywords
- malaria
- dose
- vaccination method
- recombinant viruses
- vaccine composition
- Prior art date
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
MéTODO DE VACINAçãO DOSE-REFORçO PARA MALáRIA QUE UTILIZA VìRUS RECOMBINANTES E COM POSIçãO VACINAL. A presente invenção diz respeito a um método de vacinação dose-reforço (prime-boost) que utiliza vetores adenovirais, poxvirais e proteínas purificadas para imunização de mamíferos contra malária. Além disso, a presente invenção diz respeito a composições vacinais úteis para serem utilizadas como vacina contra malária. amente aceitáveis.DOSE-REINFORCEMENT VACCINATION METHOD FOR VACINAL POSITIONING RECOMBINANT VIRUSES. The present invention relates to a prime-boost vaccination method utilizing adenoviral, poxviral vectors and purified proteins for mammalian immunization against malaria. In addition, the present invention relates to vaccine compositions useful for use as a malaria vaccine. acceptable.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0800601-6A BRPI0800601A2 (en) | 2008-01-31 | 2008-01-31 | dose-booster vaccination method for malaria using recombinant viruses and vaccine composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0800601-6A BRPI0800601A2 (en) | 2008-01-31 | 2008-01-31 | dose-booster vaccination method for malaria using recombinant viruses and vaccine composition |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0800601A2 true BRPI0800601A2 (en) | 2009-09-22 |
Family
ID=41077878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0800601-6A BRPI0800601A2 (en) | 2008-01-31 | 2008-01-31 | dose-booster vaccination method for malaria using recombinant viruses and vaccine composition |
Country Status (1)
Country | Link |
---|---|
BR (1) | BRPI0800601A2 (en) |
-
2008
- 2008-01-31 BR BRPI0800601-6A patent/BRPI0800601A2/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201591888A1 (en) | REPLICATION-DEFECT VACCINES AND VACCINE VECTORS AGAINST FLAVIVIRUSS | |
MX2021006342A (en) | Influenza virus mutants and uses therefor. | |
NO20090194L (en) | Recombinant viral vaccine | |
BR112018013387A2 (en) | recombinant vaccination vector, mva virus, vaccine or pharmaceutical composition and kit | |
WO2010019262A3 (en) | Polyvalent vaccine | |
ECSP088231A (en) | MALARIA VACCINES BASED ON ADENOVIRAL VECTORS | |
BR112014024612A2 (en) | nucleic acid, polypeptide, glycoprotein and chimeric, dengue virus epitope, chimeric flavivirus-like particle (vlp), chimeric flavivirus, and in vitro methods to identify a neutralizing antibody and to identify an immunogenic composition against a dengue virus | |
BR112014008694A2 (en) | recombinant polycistronic nucleic acid molecules | |
PH12014502438A1 (en) | Prostate-associated antigens and vaccine-based immunotherapy regimens | |
BR112012004698A2 (en) | methods for reducing virucidal activity in pcv-2 compositions and pcv-2 compositions with improved immunonugenicity. | |
MX2010008799A (en) | Process for stabilizing an adjuvant containing vaccine composition. | |
CY1120430T1 (en) | RECOMMENDED CDV COMPOSITIONS AND USES OF THESE | |
EA201391515A1 (en) | INACTIVATED DENGE VIRUS VACCINE | |
BR112015001313A2 (en) | vaccine compositions | |
BRPI1007721B1 (en) | vaccine composition for use in inducing an immune response against a rotavirus in an individual, a rotavirus strain isolated from cdc-9 and a rotavirus strain isolated from cdc-66 | |
UY33297A (en) | PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A POLYPEPTIDE THAT UNDERSTANDS AT LEAST A CXXC REASON AND HETEROLOGICAL ANTIGENS AND USES OF THE SAME | |
BR112015002131A8 (en) | RECOMBINANT VACCINIA ANKARA VIRUS (MVA), PHARMACEUTICAL COMPOSITION AND USE OF SUCH RECOMBINANT MVA | |
BR112015000585A2 (en) | mutant strains of mycoplasma hyopneumoniae | |
NZ608143A (en) | Recombinant modified vaccinia virus ankara (mva) influenza vaccine | |
AU2011280259A8 (en) | Influenza vaccine | |
MX2016001695A (en) | Combination immunogenic compositions. | |
CO6670515A2 (en) | Parapoxvirus Vectors | |
FI20115374A0 (en) | New hypoallergens | |
UY33523A (en) | ? PARAPOXVIRUS VECTORS ?. | |
MA32305B1 (en) | Inactivated attenuated live virus vaccine for bluetongue |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B03A | Publication of an application: publication of a patent application or of a certificate of addition of invention | ||
B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law | ||
B07E | Notice of approval relating to section 229 industrial property law |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B07A | Technical examination (opinion): publication of technical examination (opinion) | ||
B09B | Decision: refusal | ||
B09B | Decision: refusal |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |